Vimarsana
Biggest News Aggregation in the World

Page 2 - Timothyc Dec News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Timothyc Dec. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Timothyc Dec Today - Breaking & Trending Today

Supernus Announces Third Quarter 2023 Financial Results - Vimarsana News

Supernus Announces Third Quarter 2023 Financial Results

Raises full year 2023 adjusted operating earnings guidance range to $95 million to $110 million from previous range of $75 million to $100 millionTotal revenues of $153.9 million in the third...

Supernus to Participate in the Jefferies London Healthcare Conference - Vimarsana News

Supernus to Participate in the Jefferies London Healthcare Conference

ROCKVILLE, Md., Nov. 07, 2023 -- Supernus Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system ...

Supernus to Participate in the Jefferies London Healthcare - Vimarsana News

Supernus to Participate in the Jefferies London Healthcare

ROCKVILLE, Md., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...

Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA - Vimarsana News

Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA

ROCKVILLE, Md., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS)

Jay Glazer Teams Up with Supernus Pharmaceuticals to Raise Awareness of ADHD and his Qelbree® ... - Vimarsana News

Jay Glazer Teams Up with Supernus Pharmaceuticals to Raise Awareness of ADHD and his Qelbree® ...

Jay is sharing his story of receiving an ADHD diagnosis and eventually finding his treatment approach with Qelbree15.7 million U.S. children, teens and adults estimated to have been diagnosed with